Open AccessAcute renal failure and hyperkalaemia associated with cyclooxygenase-2 inhibitors
Author(s) -
G. L. Braden,
Michael H. O’Shea,
Jeffrey Mulhern,
Michael J. Germain
Publication year - 2004
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfg622
Subject(s) - medicine , furosemide , diuretic , discontinuation , loop diuretic , urology , hyperkalemia , endocrinology , spironolactone , aldosterone , cyclooxygenase , gastroenterology , enzyme , biochemistry , chemistry
The renal effects of cyclooxygenase-2 (COX-2) inhibitors have been incompletely elucidated, and acute renal failure (ARF) due to COX-2 inhibitors has been reported.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom